Maravai LifeSciences (MRVI) Social Stream



Maravai LifeSciences (MRVI): $13.62

-0.29 (-2.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MRVI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 381

in industry

MARAVAI LIFESCIENCES HOLDINGS INC (MRVI) Price Targets From Analysts

Use the tables below to see what analysts covering MARAVAI LIFESCIENCES HOLDINGS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-19 8 $62 $32 $53.428 $14.17 277.05%
2021-11-11 8 $65 $32 $52.714 $14.17 272.01%
2022-01-23 6 $65 $49 $56.166 $14.17 296.37%
2022-02-08 6 $59 $42 $52.333 $14.17 269.32%
2022-02-24 6 $58 $42 $48.5 $14.17 242.27%
2022-05-06 6 $54 $40 $46.2 $14.17 226.04%
2022-05-09 6 $49 $40 $44.333 $14.17 212.87%
2022-05-20 6 $49 $40 $43.833 $14.17 209.34%
2022-07-19 7 $49 $35 $42.571 $14.17 200.43%
2022-08-05 7 $40 $30 $35.571 $14.17 151.03%
2022-08-13 7 $40 $30 $34.428 $14.17 142.96%
2022-10-23 7 $37 $30 $34 $14.17 139.94%
2022-11-04 7 $32 $17 $24 $14.17 69.37%

The Trend in the Analyst Price Target


MRVI's average price target has moved down $29.74 over the prior 42 weeks.

MRVI reports an average of 61.36% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-23 6 59 49 54.833 24.46 124.17%
2022-02-08 6 59 42 52.333 28.47 83.82%
2022-02-24 6 58 42 48.400 33.50 44.48%
2022-08-13 7 40 30 34.428 26.60 29.43%
2022-08-19 7 37 30 34.000 24.48 38.89%

MRVI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.36 5 1 1 0 0 7

The Trend in the Broker Recommendations


Over the past 23 months, MRVI's average broker recommendation rating improved by 0.07.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how MARAVAI LIFESCIENCES HOLDINGS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1377.35% of that group.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, MARAVAI LIFESCIENCES HOLDINGS INC's number of analysts covering the stock is higher than 214.29% of them.
  • In the context of Pharmaceutical Products stocks, MARAVAI LIFESCIENCES HOLDINGS INC's variance in analysts' estimates is lower than -301.08% of them.
  • In the context of stocks in the large market cap category, MARAVAI LIFESCIENCES HOLDINGS INC's average analyst price target is higher than 418.01% of them.

Stocks similar to MARAVAI LIFESCIENCES HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ABCL, CGC, and TLRY.

What is the outlook for MRVI? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6633 seconds.